A detailed history of Mizuho Securities Usa LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mizuho Securities Usa LLC holds 9,445 shares of BIIB stock, worth $1.48 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,445
Previous 316,000 97.01%
Holding current value
$1.48 Million
Previous $61.3 Million 97.01%
% of portfolio
0.04%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$189.07 - $236.8 $58 Million - $72.6 Million
-306,555 Reduced 97.01%
9,445 $1.83 Million
Q3 2024

Nov 06, 2024

BUY
$189.07 - $236.8 $57.6 Million - $72.2 Million
304,778 Added 2715.9%
316,000 $61.3 Million
Q2 2024

Jul 31, 2024

BUY
$190.52 - $236.72 $2.14 Million - $2.66 Million
11,222 New
11,222 $2.6 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mizuho Securities Usa LLC Portfolio

Follow Mizuho Securities Usa LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Usa LLC with notifications on news.